Katrina S. Mark, MD, FACOG

Allegheny College, B.S.

Temple University School of Medicine, M.D.

University of Maryland Department of Obstetrics, Gynecology and Reproductive Sciences, Residency Training

Dr. Mark is an Obstetrician and Gynecologist who holds dual Board Certifications in Obstetrics and Gynecology as well as Addiction Medicine.

Her research and clinical interests center around the intersection of reproductive health and substance use/abuse. She is the Medical Director of the University of Maryland Women's Health Center at Penn and the Director of the Substance Use in Pregnancy and Parenting Outpatient Recovery and Treatment (SUPPORT) practice.

In addition to her obstetric practice, she has an ambulatory gynecology practice at the University of Maryland where she cares for people with gynecologic needs throughout their lifespans. She performs gynecologic surgeries at the University of Maryland Downtown and Midtown Campuses as well as the Veteran's Administration Hospital in Baltimore, Maryland. 

substance use in pregnancy, smoking cessation, marijuana

Mark K, Farquhar B, Chisolm M, Coleman-Cowger V, Terplan M. Knowledge, attitudes, and practices of electronic cigarette use in pregnancy. Journal of Addiction Medicine, 2015; July-Aug; 9(4): 266-272.

Mark K, Desai A, Terplan M. Marijuana use and pregnancy: prevalence, associated characteristics and birth outcomes. Archives of Women’s Mental Health, 2016; Feb; 19(1): 105-111..

Mark K, Gryczynski J, Axenfeld E, Schwartz RP, Terplan M. Pregnant women’s current and intended cannabis use in relation to their views toward legalization and knowledge of potential harm. Journal of Addiction Medicine, 2017; 11(3): 211-216.

Mark K, Terplan M. Cannabis and pregnancy: Maternal child health implications during a period of drug policy liberalization. Prev Med, 2017, Nov; 104:46-49.

Coleman-Cowger V, Oga E, Peters E, Trocin K, Koszowski B, Mark K. Prenatal screening for substance use: Comparing diagnostic validity of three screeners among pregnant women. Obstetrics and Gynecology, 2019; 133(5): 952-961.

Mark K, Pierce E, Joseph D, Crimmins S. Interaction with the justice system and other factors associated with pregnant women’s self-report and continuation of use of marijuana. Drug Alcohol Dep, 2020, 206, 107723..

Mark K, Tenorio B, Stennett C, Ghanem K, Brotman R. Bacterial vaginosis diagnostic and treatment practices in post-menopausal women: A survey of clinical practices. Menopause, 2020; 27(6): 679-683..

Mark K, Khan A, Terplan M. Cannabis use as determined by biologic testing in maternal and newborn urines during a period of drug liberalization. Substance Use and Misuse, 2020; 55(8): 1343-1346..

Heisler C, Mark K, Temkin S. Be the change you wish to see: cultivating gender equity. Am J of Obstet Gynecol, 2021; 224(3): 334-335.

Mark K, Pace L, Temkin S, Crimmins S, Terplan M. Concordance and discordance between maternal and newborn drug tests. Am J Obstet Gynecol MFM, 2021; 3(4): 100366.

Avalos C, Dula Razzolini G, Crimmins S, Mark K. Opioid prescription use after cesarean delivery: An observational cohort study. J Anesth, 2021; 35(5): 617-624.

Mark K, Otieno L, Moore E, Zehra A, Mitchell M. Association between continued cannabis use during pregnancy and symptoms of anxiety and depression. Int Rev Psychiatry, 2021 ; 33(6): 528-533.

Mark K, Saini J, Qato D. Serious psychological distress and cannabis use among pregnant women in the United States: Findings from the National Survey on Drug Use and Health, 2015- 2018. Drug Alcoh Depend, 2021; 229(Pt A): 109116.